Longitudinal tumor hypoxia imaging with [(18)F]FAZA-PET provides early prediction of nanoliposomal irinotecan (nal-IRI) treatment activity

por Zheng, Jinzi, Klinz, Stephan G., De Souza, Raquel, Fitzgerald, Jonathan, Jaffray, David A.
Publicado 2015

NTSR1 glycosylation and MMP dependent cleavage generate three distinct forms of the protein

por Libanje, Fotine, Delille, Raphael, Young, Pamela A, Rolland, Sylvie, Meyer-Losic, Florence, Lewkowicz, Elodie, Klinz, Stephan
Publicado 2023

Augmenting Experimental Gastric Cancer Activity of Irinotecan through Liposomal Formulation and Antiangiogenic Combination Therapy

por Awasthi, Niranjan, Schwarz, Margaret A., Zhang, Changhua, Klinz, Stephan G., Meyer-Losic, Florence, Beaufils, Benjamin, Thiagalingam, Arunthathi, Schwarz, Roderich E.
Publicado 2022

Longitudinal PET Imaging to Monitor Treatment Efficacy by Liposomal Irinotecan in Orthotopic Patient-Derived Pancreatic Tumor Models of High and Low Hypoxia

por Ventura, Manuela, Bernards, Nicholas, De Souza, Raquel, Fricke, Inga B., Hendriks, Bart S., Fitzgerald, Jonathan B., Lee, Helen, Klinz, Stephan G., Zheng, Jinzi
Publicado 2019

Liposomal Irinotecan Shows a Larger Therapeutic Index than Non-liposomal Irinotecan in Patient-Derived Xenograft Models of Pancreatic Cancer

por Barbier, Sandrine, Beaufils, Benjamin, de Miguel, Ricardo, Reyre, Melissa, Le Meitour, Yannick, Lortie, Andreanne, de Boisferon, Marc Hillairet, Chaumeron, Sophie, Espirito, Anne, Fossati, Lina, Lagarde, Pauline, Klinz, Stephan, Thiagalingam, Arunthathi, Lezmi, Stéphane, Meyer-Losic, Florence
Publicado 2023